Philippe Bourget

3.8k total citations
91 papers, 1.8k citations indexed

About

Philippe Bourget is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Philippe Bourget has authored 91 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 22 papers in Public Health, Environmental and Occupational Health and 16 papers in Surgery. Recurrent topics in Philippe Bourget's work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Pharmaceutical studies and practices (8 papers) and Safe Handling of Antineoplastic Drugs (8 papers). Philippe Bourget is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (20 papers), Pharmaceutical studies and practices (8 papers) and Safe Handling of Antineoplastic Drugs (8 papers). Philippe Bourget collaborates with scholars based in France, United States and Greece. Philippe Bourget's co-authors include H. Fernandez, Angélo Paci, Fabrice Vidal, R Frydman, D. Élias, Michel Ducreux, C. Lelaidier, Cindy Neuzillet, H. Carsin and Christophe Tournigand and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Philippe Bourget

89 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Bourget France 24 347 336 321 292 242 91 1.8k
Adam Frymoyer United States 26 553 1.6× 375 1.1× 343 1.1× 139 0.5× 583 2.4× 80 2.3k
Joseph E. Kiss United States 32 154 0.4× 312 0.9× 155 0.5× 311 1.1× 77 0.3× 130 3.3k
Norberto Krivoy Israel 20 163 0.5× 180 0.5× 176 0.5× 118 0.4× 247 1.0× 90 1.1k
Randall W. Yatscoff Canada 33 603 1.7× 901 2.7× 137 0.4× 623 2.1× 398 1.6× 123 2.9k
C Hershko Israel 31 293 0.8× 397 1.2× 163 0.5× 127 0.4× 57 0.2× 92 2.7k
H. Iven Germany 19 279 0.8× 355 1.1× 749 2.3× 151 0.5× 131 0.5× 58 1.8k
Michael C. Falk Australia 26 353 1.0× 468 1.4× 213 0.7× 179 0.6× 54 0.2× 67 2.2k
Matthias Stahl Germany 22 166 0.5× 500 1.5× 119 0.4× 111 0.4× 104 0.4× 60 2.1k
James W. Antoon United States 26 118 0.3× 678 2.0× 103 0.3× 139 0.5× 126 0.5× 96 1.7k
Erkki Elonen Finland 36 231 0.7× 849 2.5× 415 1.3× 115 0.4× 191 0.8× 117 4.0k

Countries citing papers authored by Philippe Bourget

Since Specialization
Citations

This map shows the geographic impact of Philippe Bourget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Bourget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Bourget more than expected).

Fields of papers citing papers by Philippe Bourget

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Bourget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Bourget. The network helps show where Philippe Bourget may publish in the future.

Co-authorship network of co-authors of Philippe Bourget

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Bourget. A scholar is included among the top collaborators of Philippe Bourget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Bourget. Philippe Bourget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neven, Bénédicte, Jean‐Sébastien Diana, Martin Castelle, et al.. (2019). Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children. Biology of Blood and Marrow Transplantation. 25(7). 1363–1373. 57 indexed citations
2.
Tardieu, Marc, Michel Zérah, Marie‐Lise Gougeon, et al.. (2017). Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial. The Lancet Neurology. 16(9). 712–720. 151 indexed citations
3.
Dariane, Charles, Olivier Lortholary, Jean‐Marc Tréluyer, et al.. (2016). Plasma and intraprostatic concentrations of ertapenem following preoperative single dose administration: a single-centre prospective experience and clinical implications—the ERTAPRO study. International Journal of Antimicrobial Agents. 48(2). 168–174. 1 indexed citations
4.
Bourget, Philippe, et al.. (2014). Routine application of Raman spectroscopy in the quality control of hospital compounded ganciclovir. International Journal of Pharmaceutics. 474(1-2). 193–201. 32 indexed citations
5.
Bourget, Philippe, Marie‐Olivia Chandesris, Fabrice Vidal, et al.. (2013). Liquid chromatography–tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis. Journal of Chromatography B. 944. 175–181. 13 indexed citations
6.
7.
Lanthier, L., et al.. (2011). Evaluation of circadian variation of blood pressure by ambulatory blood pressure monitoring in an elderly diabetic population with or without orthostatic hypotension. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. 9(1). 59–66. 5 indexed citations
8.
Amri, A., et al.. (2010). Microbiological and Physicochemical Stability of Oxycodone Hydrochloride Solutions for Patient-Controlled Delivery Systems. Journal of Pain and Symptom Management. 40(1). 87–94. 5 indexed citations
9.
Bouligand, Jérôme, et al.. (2004). High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical products. Journal of Pharmaceutical and Biomedical Analysis. 34(3). 525–530. 16 indexed citations
10.
Élias, D., Lucas Sidéris, Gabriel Liberale, et al.. (2004). Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Annals of Oncology. 15(10). 1558–1565. 106 indexed citations
11.
Élias, D., A. El Otmany, M. Bonnay, et al.. (2002). Human Pharmacokinetic Study of Heated Intraperitoneal Oxaliplatin in Increasingly Hypotonic Solutions after Complete Resection of Peritoneal Carcinomatosis. Oncology. 63(4). 346–352. 73 indexed citations
12.
Bourget, Philippe, et al.. (2001). Particularités pharmacocinétiques des médicaments administrés au sujet brûlé. Journal de Pharmacie Clinique. 20(1). 72–78. 1 indexed citations
13.
Bourget, Philippe, et al.. (1997). Suivi thérapeutique de la teicoplanine chez un sujet gravement brûlé. Annales Françaises d Anesthésie et de Réanimation. 16(4). 374–377. 7 indexed citations
14.
Bourget, Philippe, et al.. (1995). Disposition of a new rate-controlled formulation of prazosin in the treatment of hypertension during pregnancy: transplacental passage of prazosin. European Journal of Drug Metabolism and Pharmacokinetics. 20(3). 233–241. 5 indexed citations
15.
Bourget, Philippe, et al.. (1995). Models for Placental Transfer Studies of Drugs. Clinical Pharmacokinetics. 28(2). 161–180. 63 indexed citations
16.
Fernández, H., Philippe Bourget, Pascale Fabbro-Péray, et al.. (1993). Antibiotic prophylaxis against postpartum endometritis after vaginal delivery: a prospective randomized comparison between Amox-CA (Augmentin®) and abstention. European Journal of Obstetrics & Gynecology and Reproductive Biology. 50(3). 169–175. 19 indexed citations
17.
Bourget, Philippe, et al.. (1991). [Determination of the ratio of serum concentrations of tobramycin between fetus and mother at birth. A model of small scale pharmacokinetics].. PubMed. 48(8). 543–7. 6 indexed citations
18.
Bourget, Philippe, et al.. (1991). PHARMACOKINETICS OF TOBRAMYCIN IN PREGNANT WOMEN. SAFETY AND EFFICACY OF A ONCE-DAILY DOSE REGIMEN. Journal of Clinical Pharmacy and Therapeutics. 16(3). 167–176. 18 indexed citations
19.
Fernandez, H., et al.. (1991). The place of methotrexate in the management of interstitial pregnancy. Human Reproduction. 6(2). 302–306. 48 indexed citations
20.
Taburet, A M, P Attali, Philippe Bourget, J P Etienne, & E Singlas. (1989). Pharmacokinetics of ornidazole in patients with acute viral hepatitis, alcoholic cirrhosis, and extrahepatic cholestasis. Clinical Pharmacology & Therapeutics. 45(4). 373–379. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Frymoyer Breakdown of academic impact, for papers by Joseph E. Kiss Breakdown of academic impact, for papers by Norberto Krivoy Breakdown of academic impact, for papers by Randall W. Yatscoff Breakdown of academic impact, for papers by C Hershko Breakdown of academic impact, for papers by H. Iven Breakdown of academic impact, for papers by Michael C. Falk Breakdown of academic impact, for papers by Matthias Stahl Breakdown of academic impact, for papers by James W. Antoon Breakdown of academic impact, for papers by Erkki Elonen
Rankless by CCL
2026